Maxidex (Dexamethasone)

Maxidex (dexamethasone ophthalmic) is used to manage inflammatory conditions of the eye by targeting ocular immune pathways.

• Post‑operative ocular inflammation: reduces swelling, pain and redness after eye surgery.
• Uveitis: suppresses intra‑ocular inflammation to preserve vision and prevent complications.
• Allergic conjunctivitis: alleviates itching, redness and edema caused by allergic reactions.
• Other inflammatory eye conditions: controls inflammation in cases such as ocular trauma or scleritis.

• Dexamethasone binds to intracellular glucocorticoid receptors in ocular tissues, forming a complex that translocates to the nucleus and modulates gene transcription. This interaction down‑regulates pro‑inflammatory cytokines (e.g., IL‑1, TNF‑α) and up‑regulates anti‑inflammatory proteins, leading to decreased vascular permeability, inhibition of leukocyte migration, and overall suppression of the ocular immune response. It also stabilizes cell membranes, further reducing edema and improving tear film stability.

Topical ocular dexamethasone may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects

• Blurred vision: temporary loss of visual clarity after instillation.
• Ocular irritation: burning, stinging or foreign‑body sensation.
• Increased intraocular pressure: measurable rise that may require monitoring.

Serious or Rare Side Effects

• Secondary ocular infection: bacterial or fungal infection due to immunosuppression.
• Glaucoma: sustained pressure elevation leading to optic nerve damage.
• Cataract progression: accelerated lens opacity with prolonged use.

When using Maxidex, clinicians should consider several safety measures.

• Monitor intraocular pressure: check regularly to detect steroid‑induced hypertension.
• Avoid in active ocular infection: corticosteroids can worsen bacterial or fungal eye infections.
• Use cautiously in glaucoma patients: risk of pressure increase may be higher.
• Do not wear contact lenses unless advised: lenses can trap the medication and cause irritation.
• Pregnancy and lactation: safety not established, weigh benefits against potential risks.
• Store at room temperature: keep in the original container, protect from light and moisture.

Dexamethasone eye drops can interact with other ophthalmic or systemic agents.

Major Interactions (Avoid)

• Systemic corticosteroids: additive systemic glucocorticoid effects.
• Antiviral eye medications (e.g., acyclovir): may reduce antiviral efficacy.
• Topical NSAIDs: increased risk of corneal melting.

Moderate Interactions (Monitor Closely)

• Anticholinergic eye drops: may affect pupil size and accommodation.
• Beta‑blocker eye drops: potential alteration of intraocular pressure control.
• Cyclosporine ophthalmic solution: additive immunosuppressive effect.